Pilot of Osanetant to Reduce Severity of Hot Flashes in Men With Adenocarcinoma of the Prostate

NCT05647447 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Development of the drug program has been discontinued

Conditions

Prostate Adenocarcinoma

Interventions

DRUG: Osanetant

Sponsor

University of Kansas Medical Center